216 related articles for article (PubMed ID: 16225367)
1. Pharmacological treatment of ankylosing spondylitis: a systematic review.
Boulos P; Dougados M; Macleod SM; Hunsche E
Drugs; 2005; 65(15):2111-27. PubMed ID: 16225367
[TBL] [Abstract][Full Text] [Related]
2. A systematic MEDLINE analysis of therapeutic approaches in ankylosing spondylitis.
Goh L; Samanta A
Rheumatol Int; 2009 Aug; 29(10):1123-35. PubMed ID: 19562344
[TBL] [Abstract][Full Text] [Related]
3. A new strategy of drug treatment in NSAID--unresponsive ankylosing spondylitis.
Chogle AR; Mishra H; Chakravarty A
J Assoc Physicians India; 2007 May; 55():380; author reply 380-1. PubMed ID: 17844703
[No Abstract] [Full Text] [Related]
4. A new strategy of drug treatment in NSAID-unresponsive ankylosing spondylitis: combination of pamidronate and methylprednisolone monthly intravenous infusions on the background of a combination of disease modifying drugs sulfasalazine and methotrexate.
Malaviya AN; Kapoor S; Garg S; Ahmad I; Raja RR
J Assoc Physicians India; 2007 Mar; 55():193-7. PubMed ID: 17598330
[TBL] [Abstract][Full Text] [Related]
5. Conventional treatments for ankylosing spondylitis.
Dougados M; Dijkmans B; Khan M; Maksymowych W; van der Linden S; Brandt J
Ann Rheum Dis; 2002 Dec; 61 Suppl 3(Suppl 3):iii40-50. PubMed ID: 12381510
[TBL] [Abstract][Full Text] [Related]
6. Recent progress in ankylosing spondylitis treatment.
Toussirot E; Wendling D
Expert Opin Pharmacother; 2003 Jan; 4(1):1-12. PubMed ID: 12517239
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic advances in ankylosing spondylitis.
Toussirot E; Wendling D
Expert Opin Investig Drugs; 2001 Jan; 10(1):21-9. PubMed ID: 11116278
[TBL] [Abstract][Full Text] [Related]
8. Bisphosphonates as anti-inflammatory agents in ankylosing spondylitis and spondylarthropathies.
Toussirot E; Wendling D
Expert Opin Pharmacother; 2005 Jan; 6(1):35-43. PubMed ID: 15709881
[TBL] [Abstract][Full Text] [Related]
9. Treatment of ankylosing spondylitis with disease modifying antirheumatic drugs.
van der Horst-Bruinsma IE; Clegg DO; Dijkmans BA
Clin Exp Rheumatol; 2002; 20(6 Suppl 28):S67-70. PubMed ID: 12463451
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of TNFα blockers in patients with ankylosing spondylitis and non-radiographic axial spondyloarthritis: a meta-analysis.
Callhoff J; Sieper J; Weiß A; Zink A; Listing J
Ann Rheum Dis; 2015 Jun; 74(6):1241-8. PubMed ID: 24718959
[TBL] [Abstract][Full Text] [Related]
11. Sulphasalazine in ankylosing spondylitis: a double blind controlled study in 60 patients.
Dougados M; Boumier P; Amor B
Br Med J (Clin Res Ed); 1986 Oct; 293(6552):911-4. PubMed ID: 2876744
[TBL] [Abstract][Full Text] [Related]
12. Canadian Rheumatology Association Consensus on the use of anti-tumor necrosis factor-alpha directed therapies in the treatment of spondyloarthritis.
Maksymowych WP; Inman RD; Gladman D; Thomson G; Stone M; Karsh J; Russell AS;
J Rheumatol; 2003 Jun; 30(6):1356-63. PubMed ID: 12784417
[TBL] [Abstract][Full Text] [Related]
13. Golimumab: Review of the efficacy and tolerability of a recently approved tumor necrosis factor-α inhibitor.
Boyce EG; Halilovic J; Stan-Ugbene O
Clin Ther; 2010 Sep; 32(10):1681-703. PubMed ID: 21194591
[TBL] [Abstract][Full Text] [Related]
14. Ankylosing spondylitis and symptom-modifying vs disease-modifying therapy.
Akkoc N; van der Linden S; Khan MA
Best Pract Res Clin Rheumatol; 2006 Jun; 20(3):539-57. PubMed ID: 16777581
[TBL] [Abstract][Full Text] [Related]
15. Structure-modifying capacity of anti-tumour necrosis factor-alpha therapy in ankylosing spondylitis.
De Keyser F; Baeten D; Van den Bosch F; Kruithof E; Verbruggen G; Mielants H; Veys E
Drugs; 2004; 64(24):2793-811. PubMed ID: 15563249
[TBL] [Abstract][Full Text] [Related]
16. Antiinflammatory treatment with bisphosphonates in ankylosing spondylitis.
Toussirot E; Wendling D
Curr Opin Rheumatol; 2007 Jul; 19(4):340-5. PubMed ID: 17551363
[TBL] [Abstract][Full Text] [Related]
17. Tumour necrosis factor inhibitors in ankylosing spondylitis.
Reed MR; Taylor AL
Intern Med J; 2008 Oct; 38(10):781-9. PubMed ID: 18422565
[TBL] [Abstract][Full Text] [Related]
18. Indirect comparisons of the efficacy of biological agents in patients with active ankylosing spondylitis: a systematic review and meta-analysis.
Ungprasert P; Erwin PJ; Koster MJ
Clin Rheumatol; 2017 Jul; 36(7):1569-1577. PubMed ID: 28551823
[TBL] [Abstract][Full Text] [Related]
19. Serious infections in patients with ankylosing spondylitis with and without TNF blockers: a systematic review and meta-analysis of randomised placebo-controlled trials.
Fouque-Aubert A; Jette-Paulin L; Combescure C; Basch A; Tebib J; Gossec L
Ann Rheum Dis; 2010 Oct; 69(10):1756-61. PubMed ID: 19640854
[TBL] [Abstract][Full Text] [Related]
20. Ankylosing spondylitis. Current drug treatment.
Gran JT; Husby G
Drugs; 1992 Oct; 44(4):585-603. PubMed ID: 1281074
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
